In today's edition of the Daily Update, e-procurement, just-in-time 
strategies, and old economy verticals integrating New Economy technologies, 
from Prudential Financial, Bear Stearns, Stephens Inc., Argus Research, 
and Dain Rauscher Wessels. Also, Morgan Stanley rates Genzyme General (GENZ) 
a "strong buy." Click here for research:
http://www.multexinvestor.com/article.asp?docid=3657&nd=1025

***************************************************************
You are receiving this mail because you have registered for 
Multex Investor. To unsubscribe, see bottom of this message.
***************************************************************

======================== Sponsored by ========================= 
Baby Boomers Go Bust!

Long before terror struck, Baby Boomers were in big trouble. Big
houses, big SUVs, big mortgages. And No Savings! Now war and
recession. Protect yourself. Click here to learn how:

http://www.agora-inc.com/reports/STRT/BulidYourFuture
=============================================================== 

Featured in today's edition of the Daily Update:

1. SPECIAL REPORT: Bear Stearns reports on the impact of e-procurement on
industrial companies.

2. EDITOR'S PICK: Stephens Inc. analyzes the impact of Internet adoption
on select industry verticals.

3. ASK THE ANALYST: Market Edge's Tom Ventresca explains how to find
winning stocks using cyclical analysis.

4. ASK THE EXPERT: American Century's Jim Lauterwasser discusses 401(k)
plan options when changing jobs or retiring.

5. HOT REPORT: Dain Rauscher Wessels reviews three collaborative commerce
software stocks.

6. DAILY FREE SPONSOR REPORT: Morgan Stanley sets a $72 price target for
diagnostic company Genzyme General (GENZ).

7. THIRD-PARTY REVIEW: Argus Research argues that utilities are
"currently a very attractive place for investors."

8. INVESTORS' CHOICE: 3-DAY FAVORITE: Robertson Stephens expects
biotechnology stocks to have strong earnings this quarter and onwards.

9. LIVE EVENT: Learn what your options are for your retirement plan money
when you change jobs or retire.

10. FREE RESEARCH REPORT: Prudential compares two indexes and two
competing investment philosophies.

11. INVESTMENT IDEAS: The other shoe never dropped, and now the stock
price looks as beguiling as a brand new pair of pumps.

12. INVESTMENT IDEAS: Investors ignore the pundits.

13. INVESTMENTOR: You may grow comfortable with your spouse, but you might
want to lose stocks that wear curlers to bed.

======================== Sponsored by ========================= 
Paying too much for AUTO Insurance? Take a test drive on Insurance.com -
where  some of America's Best Known Carriers compete to help you SAVE. Get
no-obligation QUOTES. COMPARE with your own policy. Don't pay more than
you have to. Seek the best policy for your money - Insurance.com

http://ad.doubleclick.net/clk;3267859;5840728;z?http://www.insurance.com/entry.asp?sid=3787
=============================================================== 

1. TODAY'S SPECIAL REPORT
Bear Stearns reports on the impact of e-procurement on industrial
companies.

The firm notes that companies using Internet-enabled procurement are
better positioned to achieve sustainable advantages under certain
conditions. The report contains two "buy" recommendations among major
industrials. (66-page report for purchase - $150)
Click here.
http://www.multexinvestor.com/download.asp?docid=25157607&nd=1025


2. EDITOR'S PICK: CURRENT RESEARCH FROM THE CUTTING EDGE
Stephens Inc. analyzes the impact of Internet adoption on select industry
verticals.

The firm notes accelerated adoption of Web-based technologies in
healthcare as part of an effort to streamline financial processes,
investigates stocks in five industry verticals, and initiates coverage of
three Web stocks. (84-page report for purchase - $150)
Click here.
http://www.multexinvestor.com/download.asp?docid=25149993&nd=1025


3. ASK THE ANALYST
Market Edge's Tom Ventresca explains how to find winning stocks using
cyclical analysis.

Ventresca believes that investors can narrow down profitable equity
selections by analyzing recent stock cycles. How does this strategy work
and should you be using it? Ventresca can take your questions only today,
Thurs., Oct. 25. Ask the analyst.
Click here.
http://www.multexinvestor.com/AskTheAnalystForm.asp?&nd=1025

Register to receive a FREE weekly market commentary and get Market Edge
for 14 days FREE! Get unbiased, computer generated BUY-HOLD-SELL opinions
on 5,000 stocks and more. Click here
http://www.marketedge.com/multex.asp?Location=3.


4. ASK THE EXPERT
American Century's Jim Lauterwasser discusses 401(k) plan options when
changing jobs or retiring.

Lauterwasser explains that investors must be careful when moving money
from a 401(k) plan in order to avoid IRS penalties. What are your choices
when it comes to transferring these monies? Pose him questions until
Thurs. Nov. 1. Ask the expert.
Click here.
http://www.multexinvestor.com/AskTheExpertForm.asp?&nd=1025


5. WHAT'S HOT?
Dain Rauscher Wessels reviews three collaborative commerce software
stocks.

The firm urges investors to take "a more constructive view" of the
Web-based B2B sector and reviews i2 Technologies (ITWO), Retek (RETK), and
SAP (SAP), which have "rebounded nicely" despite poor business
fundamentals. (2-page report for purchase - $10)
Click here.
http://www.multexinvestor.com/download.asp?docid=25189629&nd=1025

======================== Sponsored by ========================= 
The Internet Analyst: Wall Street's daily and weekly industry outlook
Multex's The Internet Analyst features daily 'Net-industry specific
research highlights, investment ideas, analyst opinions, portfolio
strategies: http://www.multexinvestor.com/Analysts/HomeTIA.asp

To be sure you receive your TIA newsletter every week, click here:
http://www.multexinvestor.com/login.asp
=============================================================== 

6. DAILY FREE SPONSOR REPORT
Morgan Stanley sets a $72 price target for diagnostic company Genzyme
General (GENZ).

The firm upgrades GENZ from "outperform" to "buy" as uncertainty over an
FDA approval has been lifted, arguing that shares will now benefit from
"increasingly positive" fundamentals. Register for the firm's
free-research trial to access research on this "strong buy " rated stock.
Click here.
http://www.multexinvestor.com/download.asp?docid=4522382&sid=8&nd=1025


7. THIRD-PARTY REVIEW
Argus Research argues that utilities are "currently a very attractive
place for investors."

The firm notes that investors should benefit from solid dividend yields,
fairly inelastic demand, and continued strong fundamentals, discusses
three "buy"-rated stocks in detail, and lists more than 100 utility
stocks. (4-page report for purchase - $40)
Click here.
http://www.multexinvestor.com/download.asp?docid=25180561&nd=1025


8. INVESTORS' CHOICE: 3-DAY FAVORITE
Robertson Stephens expects biotechnology stocks to have strong earnings
this quarter and onwards.

The firm anticipates a few shortfalls mixed in with largely positive news
on the earnings front, including a few upside surprises, and reviews over
20 stocks, including six "strong buy" and 12 "buy" recommendations.
(7-page report for purchase - $25)
Click here.
http://www.multexinvestor.com/download.asp?docid=25116634&nd=1025


9. LIVE EVENT
Learn what your options are for your retirement plan money when you change
jobs or retire.

TONIGHT at 8pm ET, American Century Investment's Jim Lauterwasser will
answer questions on what your options are with your retirement plan money
when you change jobs or retire.  Don't miss this chance to learn more.
Click here.
http://oem.sageonline.com/chat/chat.asp?forumid=139&nd=1025


10. FREE RESEARCH REPORT
Prudential compares two indexes and two competing investment philosophies.

The firm shows evidence which it says proves the supremacy of the Russell
index over the S&P over the past year. The firm also urges investors to
tilt portfolios towards growth stocks. This report is free for a limited
time. Click here.
http://www.multexinvestor.com/download.asp?docid=25177260&nd=1025


11. INVESTMENT IDEAS
The other shoe never dropped, and now the stock price looks as beguiling
as a brand new pair of pumps.

Multex.com director of investment research Marc Gerstein notes that the
eponymous shoe retailer didn't miss a beat when its namesake founder got
tangled up in legal trouble, has a deep and strong management team, and
continues to be as popular with its demographic as a pop star.
Click here.
http://www.multexinvestor.com/article.asp?docid=3615&nd=1025


12. INVESTMENT IDEAS
Investors ignore the pundits.

Equity research columnist Dave Sterman says that while some telecom stocks
received continued analyst support, investors that read between the lines
can see signs of trouble for this much-beleaguered sector. Sterman reports
on the prospects for three stocks on the short list.
Click here.
http://www.multexinvestor.com/article.asp?docid=3650&nd=1025


13. THE INVESTMENTOR
You may grow comfortable with your spouse, but you might want to lose
stocks that wear curlers to bed.

Columnist William Valentine suggests that it is now time to dump defensive
stocks that have stood investors in good stead during difficult market
conditions in favor of more growth-oriented issues.
Click here.
http://www.multexinvestor.com/article.asp?docid=3653&nd=1025

===================================================================
Please send your questions and comments to:
mailto:investor.help@multex.com

If you'd like to learn more about Multex Investor, please visit:
http://www.multexinvestor.com/welcome.asp

If you can't remember your password and/or your user name, click here:
http://www.multexinvestor.com/lostinfo.asp

If you want to update your email address, please click on the url below:
http://www.multexinvestor.com/edituinfo.asp
===================================================================
To remove yourself from the mailing list for the Daily Update, please
REPLY to THIS email message with the word UNSUBSCRIBE in the subject
line. To remove yourself from all Multex Investor mailings, including
the Daily Update and The Internet Analyst, please respond with the 
words NO EMAIL in the subject line. 

You may also unsubscribe on the account update page at: 
http://www.multexinvestor.com/edituinfo.asp

===================================================================
Please email advertising inquiries to us at:
mailto:advertise@multex.com.

Be sure to check out our other newsletters, The Internet Analyst 
and The Telecomm Analyst by Multex.com. The newsletters will 
inform, educate, and entertain you with usable investment data, 
ideas, experts, and info about the Internet and telecommunications 
sectors. To see this week's issue, 
click here: 
http://www.thetelecommanalyst.com/ or 
http://www.theinternetanalyst.com/